หน้าผลลัพธ์ 12 สำหรับ หมวดธุรกิจ: การดูแลสุขภาพ อุตสาหกรรม: เทคโนโลยีชีวภาพ ตลาดหุ้น - โควตและราคา
รายชื่อหุ้นและตราสารทุนทั้งหมดพร้อมราคา มูลค่าตามราคาตลาด PE และ EPS
ประเทศทั้งหมด
- {{country.name}}
- ประเทศทั้งหมด
- สหรัฐอเมริกา (1012)
- ออสเตรเลีย (58)
- ออสเตรีย (16)
- เบลเยียม (7)
- บราซิล (16)
- แคนาดา (83)
- จีน (94)
- เดนมาร์ก (6)
- ฟินแลนด์ (4)
- ฝรั่งเศส (41)
- เยอรมนี (738)
- ฮ่องกง (46)
- อินเดีย (19)
- ไอร์แลนด์ (1)
- อิสราเอล (19)
- อิตาลี (4)
- ญี่ปุ่น (37)
- เม็กซิโก (28)
- เนเธอร์แลนด์ (3)
- นิวซีแลนด์ (1)
- นอร์เวย์ (14)
- โปแลนด์ (9)
- รัสเซีย (2)
- เกาหลีใต้ (12)
- สเปน (4)
- สวีเดน (70)
- สวิตเซอร์แลนด์ (11)
- ไต้หวัน (67)
- ไทย (2)
- ตุรกี (1)
- สหราชอาณาจักร (69)
กระดานเทรดทั้งหมด
- {{item.name}}
- กระดานเทรดทั้งหมด
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
การดูแลสุขภาพ (2611)
- {{item.name}}
- หมวดธุรกิจทั้งหมด
- การดูแลสุขภาพ (2611)
เทคโนโลยีชีวภาพ (2611)
- {{item.name}}
- อุตสาหกรรมทั้งหมด
- เทคโนโลยีชีวภาพ (2611)
- ผู้ผลิตยา - ทั่วไป (279)
- ผู้ผลิตยา - เฉพาะทางและทั่วไป (1705)
- แผนการดูแลสุขภาพ (57)
- สิ่งอำนวยความสะดวกการดูแลทางการแพทย์ (553)
- ผู้ค้าปลีกเภสัชภัณฑ์ (155)
- บริการข้อมูลด้านสุขภาพ (419)
- อุปกรณ์ทางการแพทย์ (913)
- เครื่องมือและอุปกรณ์ทางการแพทย์ (501)
- การวินิจฉัยและการวิจัย (427)
- การจำหน่ายทางการแพทย์ (138)
ชื่อ ชื่อ | ราคา ราคา |
% 24 ชม. กราฟ 7 วัน % 24 ชม. และ 7 วัน |
มูลค่าตลาด มูลค่าตามราคาตลาด | วอลุ่ม วอลุ่ม | ต่ำสุดในช่วง 24 ชม. | สูงสุดในช่วง 24 ชม. | มูลค่าตามราคาตลาด | อัตราส่วน P/E | EPS |
---|
ชื่อ ชื่อ | ราคา ราคา |
% 24 ชม. กราฟ 7 วัน % 24 ชม. และ 7 วัน |
มูลค่าตลาด มูลค่าตามราคาตลาด | วอลุ่ม วอลุ่ม | ต่ำสุดในช่วง 24 ชม. | สูงสุดในช่วง 24 ชม. | มูลค่าตามราคาตลาด | อัตราส่วน P/E | EPS | |
---|---|---|---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
Madrigal Pharmaceuticals, Inc. YDO1.F | $233.9 255.68 USD |
-2.99
|
$5.27B 5.76B USD | $50 54.66 USD | $233.9 255.68 USD | $238.8 261.04 USD | $5.27B 5.76B USD | 0 | -$15.81 -17.2 USD | |
ALK-Abelló A/S 4AJ0.F | $23.62 25.82 USD |
+1.9
|
$5.15B 5.63B USD | $1 1.09 USD | $23.08 25.23 USD | $23.62 25.82 USD | $5.15B 5.63B USD | 42.17 | $0.56 0.61 USD | |
Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
TG Therapeutics, Inc. NKB2.F | $29.83 32.6 USD |
+0.2
|
$4.87B 5.32B USD | $260 284.22 USD | $29.83 32.6 USD | $29.83 32.6 USD | $4.87B 5.32B USD | 135.56 | $0.22 0.24 USD | |
SK Biopharmaceuticals Co., Ltd. 326030.KS | $89,800 67.78 USD |
-0.44
|
$7.03T 5.31B USD | $95.94K 72.42 USD | $89,400 67.48 USD | $90,800 68.54 USD | $7.03T 5.31B USD | 0 | $0 0 USD | |
Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
Legend Biotech Corporation 9LB.F | $25.4 27.77 USD |
-0.78
|
$4.72B 5.16B USD | $1.91K 2.09K USD | $25 27.33 USD | $26 28.42 USD | $4.72B 5.16B USD | 0 | -$1.05 -1.1 USD | |
Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
Ionis Pharmaceuticals, Inc. ISI.F | $29.13 31.84 USD |
-0.78
|
$4.65B 5.09B USD | $710 776.13 USD | $29.13 31.84 USD | $29.13 31.84 USD | $4.65B 5.09B USD | 0 | -$2.65 -2.8 USD | |
Axsome Therapeutics, Inc. 19X.F | $91.68 100.22 USD |
-0.91
|
$4.59B 5.01B USD | $10 10.93 USD | $91.5 100.02 USD | $91.68 100.22 USD | $4.59B 5.01B USD | 0 | -$5.12 -5.5 USD | |
Biocon Limited BIOCON.BO | $330.65 4 USD |
-0.78
|
$396.14B 4.79B USD | $69.46K 840.29 USD | $329.1 3.98 USD | $335.95 4.06 USD | $396.14B 4.79B USD | 39.08 | $8.46 0.1 USD | |
Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
Alpine Immune Sciences ALPN | $64.97 — |
0
|
$4.46B — | $0 — | $0 — | $0 — | $4.46B — | 0 | $0 — | |
Zealand Pharma A/S ZLDPF | $62.36 — |
0
|
$4.41B — | $100 — | $62.34 — | $62.34 — | $4.41B — | 0 | -$2.63 — | |
ALK-Abelló A/S 0OIR.IL | $149.45 21.91 USD |
0
|
$30B 4.4B USD | $1.63K 238.99 USD | $170.5 25 USD | $175.6 25.75 USD | $30B 4.4B USD | 92.82 | $1.61 0.24 USD | |
Sarepta Therapeutics, Inc. S1RP34.SA | $10.83 2.2 USD |
-2.26
|
$21.3B 4.32B USD | $95 19.25 USD | $10.82 2.19 USD | $11.2 2.27 USD | $21.3B 4.32B USD | 0 | -$0.75 -0.1 USD | |
Vaxcyte, Inc. 5VA.MU | $30.2 33.01 USD |
0
|
$3.9B 4.26B USD | $0 0 USD | $30.2 33.01 USD | $30.2 33.01 USD | $3.9B 4.26B USD | 0 | -$3.54 -3.8 USD | |
Agios Pharmaceuticals, Inc. AGIO.MX | $1,222 72.36 USD |
0
|
$70.77B 4.19B USD | $0 0 USD | $1,222 72.36 USD | $1,222 72.36 USD | $70.77B 4.19B USD | 5.16 | $236.58 14.01 USD | |
Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.6 8.31 USD |
+3.4
|
$3.75B 4.1B USD | $160 174.9 USD | $7.6 8.31 USD | $7.6 8.31 USD | $3.75B 4.1B USD | 21.71 | $0.35 0.38 USD | |
Vaxcyte, Inc. 5VA.F | $28.4 31.05 USD |
0
|
$3.72B 4.07B USD | $160 174.9 USD | $28.4 31.05 USD | $28.4 31.05 USD | $3.72B 4.07B USD | 0 | -$3.54 -3.8 USD | |
BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
Rhythm Pharmaceuticals, Inc. 1RV.F | $54 59.03 USD |
-0.92
|
$3.52B 3.84B USD | $11 12.02 USD | $54 59.03 USD | $54.5 59.58 USD | $3.52B 3.84B USD | 0 | -$2.48 -2.7 USD | |
CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
Akero Therapeutics, Inc. 0K4.F | $42.97 46.97 USD |
+0.68
|
$3.43B 3.74B USD | $7 7.65 USD | $42.97 46.97 USD | $43 47 USD | $3.43B 3.74B USD | 0 | -$3.33 -3.6 USD | |
CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
Merus N.V. 2GH.F | $42.6 46.57 USD |
+13.9
|
$3.38B 3.7B USD | $300 327.94 USD | $39 42.63 USD | $42.6 46.57 USD | $3.38B 3.7B USD | 0 | -$3.69 -4.03 USD | |
Sarepta Therapeutics, Inc. AB3A.F | $34.19 37.37 USD |
-2.95
|
$3.36B 3.67B USD | $298 325.75 USD | $34.19 37.37 USD | $34.19 37.37 USD | $3.36B 3.67B USD | 0 | -$2.34 -2.5 USD | |
ACADIA Pharmaceuticals Inc. DR6.F | $18.89 20.64 USD |
-1.38
|
$3.26B 3.56B USD | $300 327.94 USD | $18.89 20.64 USD | $18.89 20.64 USD | $3.26B 3.56B USD | 15.60 | $1.21 1.32 USD | |
Zealand Pharma A/S 0NZU.IL | $406.95 59.67 USD |
+0.41
|
$24.26B 3.56B USD | $9.75K 1.43K USD | $395.7 58.02 USD | $409.8 60.09 USD | $24.26B 3.56B USD | 0 | -$15.13 -2.2 USD | |
Cytokinetics, Incorporated KK3A.F | $26.4 28.86 USD |
-1.49
|
$3.23B 3.53B USD | $150 163.97 USD | $26.4 28.86 USD | $26.6 29.08 USD | $3.23B 3.53B USD | 0 | -$4.69 -5.1 USD | |
Krystal Biotech, Inc. 4KB.F | $108.7 118.82 USD |
-1.9
|
$3.2B 3.5B USD | $350 382.6 USD | $108.7 118.82 USD | $109.6 119.81 USD | $3.2B 3.5B USD | 29.37 | $3.7 4.04 USD | |
Krystal Biotech, Inc. 4KB.SG | $109.2 119.37 USD |
-1.09
|
$3.2B 3.5B USD | $0 0 USD | $109.2 119.37 USD | $109.6 119.81 USD | $3.2B 3.5B USD | 29.51 | $3.7 4.04 USD | |
Genscript Biotech GNNSF | $1.36 — |
0
|
$3.42B — | $750 — | $1.3 — | $1.3 — | $3.42B — | 0 | -$0.08 — | |
Zai Lab Limited 1ZL.F | $27 29.51 USD |
-4.26
|
$3.12B 3.41B USD | $230 251.42 USD | $27 29.51 USD | $28.2 30.83 USD | $3.12B 3.41B USD | 0 | -$2.22 -2.4 USD | |
Genscript Biotech Corporation G51.F | $1.36 1.49 USD |
+5.06
|
$3.03B 3.31B USD | $74 80.89 USD | $1.36 1.49 USD | $1.36 1.49 USD | $3.03B 3.31B USD | 0 | -$0.07 -0.07 USD | |
Ultragenyx Pharmaceutical Inc. UP0.F | $31 33.89 USD |
0
|
$2.99B 3.27B USD | $54 59.03 USD | $31 33.89 USD | $31 33.89 USD | $2.99B 3.27B USD | 0 | -$5.17 -5.6 USD | |
Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.93B 3.2B USD | 0 | $0 0 USD | |
Syngene International Limited SYNGENE.BO | $637.4 7.71 USD |
+0.33
|
$256.09B 3.1B USD | $19.67K 237.97 USD | $632 7.65 USD | $640 7.74 USD | $256.09B 3.1B USD | 51.52 | $12.37 0.15 USD | |
VitaSpring Biomedical VSBC | $1 — |
0
|
$3.1B — | $100 — | $1 — | $1 — | $3.1B — | 0 | $0 — | |
Camurus AB (publ) 7CA.F | $46.78 51.14 USD |
-3.03
|
$2.75B 3.01B USD | $60 65.59 USD | $46.78 51.14 USD | $46.78 51.14 USD | $2.75B 3.01B USD | 55.69 | $0.84 0.92 USD | |
Viking Therapeutics, Inc. 1VT.F | $23.7 25.9 USD |
-4.72
|
$2.69B 2.94B USD | $14 15.3 USD | $23.61 25.8 USD | $23.71 25.91 USD | $2.69B 2.94B USD | 0 | -$1.03 -1.1 USD | |
Catalyst Pharmaceuticals, Inc. CN2.F | $20.97 22.92 USD |
-0.85
|
$2.65B 2.89B USD | $12 13.12 USD | $20.97 22.92 USD | $20.97 22.92 USD | $2.65B 2.89B USD | 15.08 | $1.39 1.52 USD | |
Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $51.7 56.52 USD |
-1.52
|
$2.64B 2.89B USD | $19 20.77 USD | $51.7 56.52 USD | $51.7 56.52 USD | $2.64B 2.89B USD | 18.93 | $2.73 2.98 USD | |
Morphic Holding MORF | $56.99 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
MorphoSys AG MOR | $18.96 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
MorphoSys AG MOR.VI | $68.15 74.5 USD |
0
|
$2.57B 2.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.57B 2.81B USD | 0 | $0 0 USD | |
MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
MorphoSys AG MOR.DE | $67.25 73.51 USD |
0
|
$2.53B 2.77B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.53B 2.77B USD | 0 | $0 0 USD | |
Scholar Rock Holding Corporation 2QK.F | $26.6 29.08 USD |
-0.75
|
$2.53B 2.76B USD | $20 21.86 USD | $26.6 29.08 USD | $26.6 29.08 USD | $2.53B 2.76B USD | 0 | -$2.26 -2.4 USD | |
MorphoSys AG MPSYF | $73.27 — |
0
|
$2.76B — | $0 — | $0 — | $0 — | $2.76B — | 0 | $0 — | |
Crinetics Pharmaceuticals, Inc. 6Z4.F | $26 28.42 USD |
-1.52
|
$2.47B 2.7B USD | $60 65.59 USD | $26 28.42 USD | $26 28.42 USD | $2.47B 2.7B USD | 0 | -$3.37 -3.6 USD | |
MorphoSys AG 0NDV.IL | $67.6 73.9 USD |
0
|
$2.34B 2.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.34B 2.56B USD | 0 | $0 0 USD | |
SK bioscience Co.,Ltd. 302440.KS | $42,850 32.34 USD |
-2.83
|
$3.29T 2.48B USD | $163.28K 123.25 USD | $42,450 32.04 USD | $43,900 33.14 USD | $3.29T 2.48B USD | 0 | $0 0 USD | |
ABL Bio Inc. 298380.KQ | $64,300 48.54 USD |
-2.43
|
$3.09T 2.33B USD | $557.16K 420.57 USD | $62,600 47.25 USD | $65,600 49.52 USD | $3.09T 2.33B USD | 0 | $0 0 USD | |
Bavarian Nordic A/S 0DPB.IL | $167.58 24.57 USD |
-0.92
|
$15.73B 2.31B USD | $1.58K 231.66 USD | $165.1 24.21 USD | $171.15 25.09 USD | $15.73B 2.31B USD | 11.89 | $14.09 2.07 USD | |
Xenon Pharmaceuticals Inc. XP0.F | $26.8 29.3 USD |
0
|
$2.06B 2.25B USD | $60 65.59 USD | $26.8 29.3 USD | $26.8 29.3 USD | $2.06B 2.25B USD | 0 | -$2.85 -3.1 USD | |
Galapagos NV G1LP34.SA | $8.09 1.64 USD |
+1.13
|
$10.84B 2.2B USD | $1 0.2 USD | $8.09 1.64 USD | $8.09 1.64 USD | $10.84B 2.2B USD | 0 | -$0.88 -0.1 USD | |
Ascentage Pharma Group International 36X.F | $5.4 5.9 USD |
-3.57
|
$1.99B 2.18B USD | $1 1.09 USD | $5.4 5.9 USD | $5.65 6.18 USD | $1.99B 2.18B USD | 0 | -$0.16 -0.1 USD | |
Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.99B 2.18B USD | 0 | $0 0 USD | |
ImmunityBio, Inc. 26CA.F | $2.21 2.41 USD |
-7.27
|
$1.98B 2.16B USD | $5.19K 5.68K USD | $2.2 2.41 USD | $2.44 2.66 USD | $1.98B 2.16B USD | 0 | -$0.51 -0.5 USD | |
BioCryst Pharmaceuticals, Inc. BO1.F | $9.11 9.95 USD |
+3.59
|
$1.96B 2.15B USD | $200 218.63 USD | $9.07 9.92 USD | $9.11 9.95 USD | $1.96B 2.15B USD | 0 | -$0.23 -0.2 USD | |
Apellis Pharmaceuticals, Inc. 1JK.F | $15.23 16.65 USD |
+3.79
|
$1.94B 2.12B USD | $100 109.31 USD | $14.99 16.39 USD | $15.23 16.65 USD | $1.94B 2.12B USD | 0 | -$1.6 -1.7 USD | |
Mirum Pharmaceuticals, Inc. 08D.F | $37.2 40.66 USD |
-1.06
|
$1.93B 2.11B USD | $26 28.42 USD | $37.2 40.66 USD | $37.6 41.1 USD | $1.93B 2.11B USD | 0 | -$1.43 -1.5 USD | |
Bavarian Nordic A/S BVNKF | $26.8 — |
0
|
$2.09B — | $210 — | $24.95 — | $24.95 — | $2.09B — | 10.50 | $2.55 — | |
Veracyte, Inc. 12V.F | $24 26.24 USD |
-0.83
|
$1.89B 2.06B USD | $261 285.31 USD | $24 26.24 USD | $24 26.24 USD | $1.89B 2.06B USD | 64.86 | $0.37 0.4 USD | |
Arrowhead Pharmaceuticals, Inc. HDP1.F | $13.46 14.71 USD |
+0.6
|
$1.86B 2.03B USD | $80 87.45 USD | $13.46 14.71 USD | $13.46 14.71 USD | $1.86B 2.03B USD | 0 | -$1.1 -1.2 USD | |
Vericel Corporation ATQP.F | $36.2 39.57 USD |
0
|
$1.83B 2B USD | $130 142.11 USD | $36.2 39.57 USD | $36.2 39.57 USD | $1.83B 2B USD | 905.00 | $0.04 0.04 USD | |
Denali Therapeutics Inc. 4DN.MU | $12.18 13.31 USD |
-0.25
|
$1.77B 1.93B USD | $0 0 USD | $12.18 13.31 USD | $12.18 13.31 USD | $1.77B 1.93B USD | 0 | -$2.37 -2.5 USD | |
Bavarian Nordic A/S BV3.F | $22.21 24.28 USD |
-1.29
|
$1.75B 1.92B USD | $600 655.88 USD | $22.21 24.28 USD | $22.46 24.55 USD | $1.75B 1.92B USD | 9.87 | $2.25 2.46 USD | |
Denali Therapeutics Inc. 4DN.F | $11.98 13.1 USD |
-0.29
|
$1.74B 1.9B USD | $50 54.66 USD | $11.98 13.1 USD | $11.98 13.1 USD | $1.74B 1.9B USD | 0 | -$2.37 -2.5 USD | |
Ligand Pharmaceuticals Incorporated LGDN.F | $87 95.1 USD |
-1.14
|
$1.74B 1.9B USD | $20 21.86 USD | $87 95.1 USD | $89 97.29 USD | $1.74B 1.9B USD | 0 | -$6.46 -7.06 USD | |
Galapagos GLPGF | $27.5 — |
0
|
$1.9B — | $190 — | $26.2 — | $26.2 — | $1.9B — | 0 | -$3.09 — | |
Amicus Therapeutics, Inc. AM6.F | $5.5 6.01 USD |
-0.9
|
$1.7B 1.86B USD | $481 525.8 USD | $5.5 6.01 USD | $5.5 6.01 USD | $1.7B 1.86B USD | 0 | -$0.08 -0.08 USD | |
Galapagos NV GLPG.VI | $25.36 27.72 USD |
+0.08
|
$1.68B 1.84B USD | $0 0 USD | $25.36 27.72 USD | $25.84 28.25 USD | $1.68B 1.84B USD | 0 | -$2.73 -2.9 USD | |
Galapagos NV GXE.F | $25.16 27.5 USD |
-0.71
|
$1.68B 1.84B USD | $150 163.97 USD | $25.16 27.5 USD | $25.38 27.74 USD | $1.68B 1.84B USD | 0 | -$2.73 -2.9 USD | |
Galapagos NV GXEA.F | $25.4 27.77 USD |
0
|
$1.68B 1.84B USD | $4 4.37 USD | $25.4 27.77 USD | $25.4 27.77 USD | $1.68B 1.84B USD | 0 | -$2.73 -2.9 USD | |
Genus GENSF | $27.87 — |
0
|
$1.83B — | $4 — | $29.35 — | $29.35 — | $1.83B — | 0 | -$0.08 — | |
Fusion Pharmaceuticals FUSN | $21.41 — |
0
|
$1.82B — | $0 — | $0 — | $0 — | $1.82B — | 0 | $0 — | |
Mesoblast MEOBF | $1.43 — |
0
|
$1.82B — | $1K — | $1.5 — | $1.5 — | $1.82B — | 0 | -$0.09 — | |
Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
BioArctic AB (publ) 0RV2.IL | $180.5 17.62 USD |
+1.55
|
$18.06B 1.76B USD | $21.99K 2.15K USD | $176 17.18 USD | $183.1 17.87 USD | $18.06B 1.76B USD | 58.79 | $3.07 0.3 USD | |
PeptiDream PPTDF | $13.53 — |
0
|
$1.75B — | $500 — | $12 — | $12 — | $1.75B — | 17.12 | $0.79 — | |
Genus plc GBE.F | $23.6 25.8 USD |
-2.48
|
$1.59B 1.73B USD | $610 666.81 USD | $23.6 25.8 USD | $23.6 25.8 USD | $1.59B 1.73B USD | 0 | -$0.07 -0.07 USD | |
Everest Medicines Limited 6HN.F | $4.72 5.16 USD |
-2.48
|
$1.57B 1.71B USD | $212 231.74 USD | $4.72 5.16 USD | $4.72 5.16 USD | $1.57B 1.71B USD | 0 | -$0.4 -0.4 USD | |
Agios Pharmaceuticals, Inc. 8AP.F | $25.8 28.2 USD |
-1.53
|
$1.53B 1.67B USD | $54 59.03 USD | $25.8 28.2 USD | $25.8 28.2 USD | $1.53B 1.67B USD | 2.52 | $10.23 11.18 USD | |
Centessa Pharmaceuticals plc 260.F | $10.6 11.59 USD |
-2.75
|
$1.52B 1.67B USD | $0 0 USD | $10.6 11.59 USD | $11 12.02 USD | $1.52B 1.67B USD | 0 | -$1.67 -1.8 USD | |
Pharma Mar, S.A. 0RC6.IL | $84.2 92.04 USD |
-4.43
|
$1.52B 1.66B USD | $273 298.43 USD | $81.5 89.09 USD | $91.65 100.19 USD | $1.52B 1.66B USD | 75.85 | $1.11 1.21 USD | |
Pharma Mar PHMMF | $96.2 — |
-8.9
|
$1.66B — | $100 — | $96.2 — | $96.2 — | $1.66B — | 75.15 | $1.28 — | |
BB Biotech AG BIOEE.SW | $25.35 28.84 USD |
0
|
$1.45B 1.65B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.45B 1.65B USD | 0 | $0 0 USD | |
Pharma Mar, S.A. PMRA.F | $87.3 95.43 USD |
-0.96
|
$1.51B 1.65B USD | $16 17.49 USD | $87.3 95.43 USD | $87.3 95.43 USD | $1.51B 1.65B USD | 77.25 | $1.13 1.24 USD | |
BioArctic AB (publ) B9A.F | $16.59 18.14 USD |
-2.7
|
$1.47B 1.6B USD | $500 546.57 USD | $16.59 18.14 USD | $16.6 18.15 USD | $1.47B 1.6B USD | 17.64 | $0.94 1.03 USD | |
IDEAYA Biosciences, Inc. 30J.SG | $16.2 17.71 USD |
-1.82
|
$1.46B 1.6B USD | $0 0 USD | $16 17.49 USD | $16.2 17.71 USD | $1.46B 1.6B USD | 0 | -$3.24 -3.5 USD | |
IDEAYA Biosciences, Inc. 30J.F | $16.4 17.93 USD |
-2.38
|
$1.46B 1.6B USD | $115 125.71 USD | $16.4 17.93 USD | $16.4 17.93 USD | $1.46B 1.6B USD | 0 | -$3.24 -3.5 USD | |
Biotest Aktiengesellschaft BIO3.VI | $30 32.79 USD |
+0.67
|
$1.44B 1.58B USD | $0 0 USD | $30 32.79 USD | $30.2 33.01 USD | $1.44B 1.58B USD | 0 | -$0.63 -0.6 USD | |
Biotest Aktiengesellschaft BIO3.F | $29.6 32.36 USD |
0
|
$1.44B 1.58B USD | $3 3.28 USD | $29.6 32.36 USD | $29.6 32.36 USD | $1.44B 1.58B USD | 0 | -$0.63 -0.6 USD | |
Biotest Aktiengesellschaft BIO.F | $42.6 46.57 USD |
+0.47
|
$1.44B 1.58B USD | $30 32.79 USD | $42.4 46.35 USD | $42.6 46.57 USD | $1.44B 1.58B USD | 0 | -$0.63 -0.6 USD | |
ไม่มีหุ้นที่ชื่นชอบ
คุณยังไม่มีหุ้นที่ชื่นชอบ กรุณาเพิ่มลงในรายการโปรดเพื่อดูที่นี่ |